Related Experiment Video

Updated: May 14, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Epidemiologic and clinical implications of second-generation pneumococcal conjugate vaccines

Carmen Muñoz-Almagro1, Adoracion Navarro-Torne, Roman Pallares

  • 1Molecular Microbiology Department, University Hospital Sant Joan de Déu, Passeig Sant Joan de Déu, Esplugues, 08950, Barcelona, Spain, cma@hsjdbcn.org.

Current Infectious Disease Reports
|February 6, 2013
PubMed

Insights

The review examines the benefits and drawbacks of newer pneumococcal conjugate vaccines, focusing on the 13-valent vaccine for both children and adults. It highlights key considerations for the second generation of these important vaccines.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatrics
  • Public Health

Background:

  • Pneumococcal conjugate vaccines (PCVs) are crucial for preventing invasive pneumococcal disease.
  • The evolution of PCVs has led to the development of second-generation vaccines with broader serotype coverage.
  • Understanding the performance of these newer vaccines is essential for optimizing immunization strategies.

Purpose of the Study:

  • To review the published literature on the advantages and challenges of second-generation pneumococcal conjugate vaccines.
  • To specifically evaluate the 13-valent pneumococcal conjugate vaccine (PCV13) in pediatric and adult populations.
  • To provide insights into the clinical and public health implications of PCV13 use.

Main Methods:

  • Comprehensive literature search of published studies on pneumococcal conjugate vaccines.
  • Focus on studies detailing the efficacy, effectiveness, and safety of the 13-valent pneumococcal conjugate vaccine (PCV13).
  • Analysis of data pertaining to both pediatric and adult populations.

Main Results:

  • Second-generation PCVs, particularly PCV13, offer expanded protection against additional pneumococcal serotypes.
  • Advantages include potentially enhanced herd immunity and reduced disease burden in unvaccinated individuals.
  • Challenges may involve serotype replacement, vaccine effectiveness in specific age groups, and logistical considerations for implementation.

Conclusions:

  • The 13-valent pneumococcal conjugate vaccine represents a significant advancement in pneumococcal disease prevention.
  • Ongoing surveillance and research are necessary to fully understand the long-term impact and address any emerging challenges.
  • Optimizing the use of PCV13 in children and adults requires careful consideration of its benefits and limitations.

More Related Videos

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.